Introduction
Most regulatory affairs job searches run entirely on job boards: scan the postings, apply, wait. It works, but it puts you in competition with everyone else who saw the same listing the same day, reacting only after a company has already decided it needs to hire. A target company list flips that. Instead of waiting for postings to appear, you identify companies likely to need regulatory affairs talent soon, based on signals that predict hiring, and you position yourself with those companies before the req goes live — or you apply the moment it does, already having done the homework that makes your application read as informed rather than generic.
This isn't a replacement for job board searching. It's a parallel track that tends to surface opportunities earlier and gives you a real basis for outreach that isn't a cold, generic message.
Start With Pipeline, Not Headcount
Regulatory affairs hiring tends to track a company's pipeline stage more closely than its overall size. A company approaching a pivotal trial readout, a planned submission, or an anticipated approval decision often needs to build out regulatory capacity months in advance of that milestone, and again afterward to manage the post-approval workload. ClinicalTrials.gov is a genuinely useful, free source for this: searching by sponsor and filtering for trials in later phases gives you a rough sense of which companies are approaching submission-relevant milestones. Public company investor relations pages and pipeline pages serve the same purpose for companies that report on trial progress and regulatory milestones to shareholders. Neither source tells you a company is hiring right now, but both tell you where hiring is more likely to happen soon, which is the whole point of a target list built proactively rather than reactively.
It helps to think in terms of a rough timeline rather than a single moment. A company approaching a pivotal readout may start building regulatory capacity well before the data is even in hand, anticipating the submission work that follows a positive result. The same company, once it has an approval, often needs to staff up again for post-market obligations — labeling maintenance, safety reporting, and lifecycle management — that a pre-approval regulatory team wasn't necessarily built to handle. Tracking where a target company sits on that timeline, rather than treating "pipeline stage" as a single static fact, makes the signal considerably more useful.
Map the Ecosystem Beyond Sponsors
A target list focused only on drug and device sponsors misses a large share of where regulatory affairs jobs actually live. Contract research organizations and specialty CDMOs employ substantial regulatory affairs staff serving multiple sponsor clients at once, and their hiring often tracks overall industry activity rather than any single product's timeline, which can make them a steadier target than a single sponsor company. Regulatory consultancies are worth including for the same reason, and they're often more open to conversations with candidates who aren't actively applying to a specific posting, since consultancies are frequently building bench strength ahead of client demand. RAPS and DIA member directories, along with conference exhibitor and sponsor lists, are a practical way to surface consultancies and CROs you might not encounter through job boards alone.
Reading the Signals That Predict Hiring
A handful of concrete signals are worth tracking as you build the list. A recent funding round, IPO, or public offering for a smaller biotech — visible through SEC filings on EDGAR for US-listed or newly public companies — often precedes a hiring push, since new capital frequently funds exactly the kind of regulatory and clinical build-out that gets a product to its next milestone. Public announcements of an FDA approval, a submission acceptance, or a positive trial readout are worth watching too, since post-milestone hiring is common as companies staff up for the next phase of work. Expansion into a new therapeutic area or a new geography is another reliable signal, since it usually requires regulatory expertise the company doesn't yet have in-house. And a new VP or Head of Regulatory Affairs hire at a company is frequently a leading indicator on its own: new regulatory leaders tend to build out their teams within the following several months, and that hire is often visible on LinkedIn well before any posting appears.
Building and Organizing the List
A simple spreadsheet works better than any specialized tool for this. Useful columns include the company name, the signal that put them on your list and when you noticed it, the therapeutic area or product type, any contacts you have or want to make there, the status of any outreach or application, and a date to revisit. Twenty to forty companies is a reasonable range for most searches — enough to give you real optionality without spreading your attention so thin that no single relationship gets enough follow-through to matter.
If you're early in your career and don't have an existing network to draw on, the list itself becomes the starting point for building one. Following a company's regulatory leadership on LinkedIn, engaging thoughtfully with things they post, and reaching out for a short informational conversation are all reasonable ways to start a relationship with a company before you have any contacts there at all.
It's worth being honest about the limits of a spreadsheet-only approach, too. The tool doesn't do the work for you; it just organizes the work so you don't lose track of it. A list of forty companies with no follow-through on any of them is no more useful than no list at all. If you only have the bandwidth to genuinely research and engage with a handful of companies at a time, a shorter, more carefully maintained list will usually outperform a long one that never gets revisited.
Using the List Strategically
The list is most useful as a basis for informational outreach, not just application timing. A short, specific message to someone on a company's regulatory team — one that references the actual signal that put the company on your list, rather than a generic "I'd love to learn more about opportunities" — tends to get a meaningfully better response rate than a cold application into an applicant tracking system. LinkedIn's search operators are useful here too: searching for people with regulatory affairs titles at a specific target company, or using the platform's built-in alerts for new postings at companies you're tracking, keeps you from having to manually recheck each company's careers page. Attending a conference where several of your target companies exhibit or send staff is another practical way to convert a name on a spreadsheet into an actual conversation.
Timing matters as much as the message itself. Reaching out right after a company announces a funding round, an approval, or a new regulatory leadership hire — while the news is fresh and the company is visibly in growth mode — tends to land better than a generic message sent months later with no clear reason for the timing. Referencing that specific news in your message also does double duty: it shows you're paying attention to the industry generally, not just to that one company, which is itself a useful thing for a regulatory affairs candidate to demonstrate.
Keeping It Current
A target list that isn't reviewed goes stale fast in an industry where pipeline status and funding situations change quickly. A brief monthly review — pruning companies where the signal has cooled or the opportunity clearly passed, and adding new ones as fresh news breaks — keeps the list actually useful rather than becoming a static document you built once and never revisited. The habit matters more than the tool.
Setting Up Alerts So the List Maintains Itself
A monthly manual review is easier to sustain if most of the signal-gathering happens automatically in between. Free news alerts for a target company's name, paired with an alert for a therapeutic area or product type you're focused on, catch a meaningful share of the funding and approval news that matters without requiring you to check a dozen sources by hand. LinkedIn's own alert settings for company pages and specific people can flag a new regulatory leadership hire or a company update shortly after it happens, which is often the single most useful trigger for adding a company to the list. None of this needs to be sophisticated. The goal is simply to lower the effort required to keep noticing things, so the list reflects current reality rather than the snapshot you built when you first started the search.
Conclusion
A target company list won't replace the job boards, and it's genuinely more work than scanning postings and clicking apply. What it buys you is a head start: earlier visibility into where hiring is likely, a real reason for the outreach you send, and applications that read as informed rather than generic when a role does open. In a field where regulatory hiring often tracks predictable pipeline and funding signals, that head start is available to anyone willing to do the research.